Kymab is a clinical-stage biopharmaceutical company developing fully human monoclonal antibody therapeutics with a focus on immune-mediated diseases and immuno-oncology using its proprietary, integrated platforms collectively called IntelliSelect®. Kymab’s IntelliSelect Transgenic platforms contain a full diversity of human antibodies, making them the most comprehensive antibody platforms available. The company was founded in 2010 and is based in Cambridge, the United Kingdom.

Caris Molecular Profiling Institute, Inc. provides research and laboratory testing services. It offers tests to help oncologists to understand and treat cancer patients with personalized treatment plans based on the molecular characteristics of their tumors. The company offers services to the hospitals, physicians, and clinical research sponsors. Caris Molecular Profiling Institute was founded on 1996 and is headquartered in Phoenix, AZ.

Canget BioTekpharma is a biotech and biopharma company used to develop novel, cancer-targeting anticancer agents. It provides low toxic and cancer-targeting anticancer agents for patients, enabling medical practitioners to improve patient survival time and survival rate through controlling cancer cell drug resistance and tumor relapse. The company focuses on the development of novel, cancer-targeting anticancer agents that exhibit low toxicity to normal tissue and high efficacy to cancer. Canget BioTekpharma was established in 2012 and is headquartered in Buffalo, New York.

Their Company has developed a biomarker-based cancer drugs based on accumulated developmental experience and know-how. They have a new drug development institute including synthetic and bio-research and management support center. Utilizing R&D infrastructure from Asan Medical Center in Seoul Republic of Korea they are focusing on developing new drugs that overcome resistance of existing therapeutic approaches. Additionally they are focusing on developing first-in-class biomarker-based drugs for medical unmet needs in various cancers such as colon cancer, lung cancer and liver cancer.

The United States Department of Veterans Affairs (VA) is a federal Cabinet-level agency that provides near-comprehensive healthcare services to eligible military veterans at VA medical centers and outpatient clinics located throughout the country; several non-healthcare benefits including disability compensation, vocational rehabilitation, education assistance, home loans, and life insurance; and provides burial and memorial benefits to eligible veterans and family members at 135 national cemeteries.

Tianjin First Central Hospital (Chinese: 天津市第一中心医院) is a hospital in the Chinese metropolis of Tianjin. In addition to other medical services and teaching, it is a major center for liver transplants. It was founded in 1949.

Syntekabio is a Korean biotech firm, developing personal genome map which is expected to enable personalized medical service. The company also provides a technology for collecting and integrating decrypted whole genome data.

Genome International Corporation (GIC) is a research-driven firm providing innovative bioinformatics products and custom research solutions for corporate, government, and academic laboratories in biomedical sciences. Their scientists and engineers are passionate about delivering high quality yet cost effective products and services by innovating advances in bioinformatics and information technologies to optimize the management, analysis and mining of high-throughput molecular biology data.

Foundation Medicine, Inc. is a public American company based in Cambridge, Massachusetts which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.

Suzhou Semico Gene Technology Co., Ltd., established on 2016-04-22, Business scope includes gene technology development,technical consulting,Technical Services,technology transfer;Conference Services;product design;software development;Application software service;Natural science research and experimental development;Medical Research and Experimental Development;Sell ​​self-developed products.Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Suzhou Rude Technology Co., Ltd., established on 2008-01-07, Business scope includes technology development in the field of computer software,transfer,Consulting and Services;Mechanical automation control equipment manufacturing,processing,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

VigNet, Inc., part of Vignet IT Solutions Pvt Ltd., is an American company that provides healthcare technology services.

Assistance Publique H��pitaux de Marseille is a private company headquartered in Marseille, France, specializing in general medical and surgical hospitals.

Ningbo Health Gene Technologies Co. Ltd. is a Chinese company that develops and researches nucleic acid testing solutions for molecular diagnostics, clinical research and forensic analysis.

Cornell provides education about the earth and atmospheric sciences. They offer summer and winter sessions. Their students contact them through phone and email services.

Seoul National University Hospital (서울대학교병원) is one of the oldest and biggest hospitals in South Korea. It is a general and teaching hospital of Seoul National University's College of Medicine. Except SNUH Healthcare System Gangnam Center, all branches have an emergency department (ED).

Istituto Biochimico Italiano Giovanni Lorenzini SpA develops, manufactures and distributes pharmaceutical products. The company was founded by Giovanni Lorenzini in 1918 and is headquartered in Aprilia, Italy.